TTrialPathMatch Me to Trials
← Back to trials
RecruitingObesityRoux-en-y Anastomosis SiteWeight Gain

Comparing Reduction With ESD- Versus APC-TORe

Eligible age

18+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The goal of this clinical trial is to compare two variations of the same procedure used to assist with weight loss in patients who have a history of Roux-en-Y gastric bypass who have experienced weight regain. The procedure being studied is called the Transoral Outlet Reduction (TORe), and the trial will compare two different ways to complete the TORe procedure. The main question\[s\] it aims to answer are: * Which variation of the TORe procedure results in more weight loss? * Which variation of the TORe is safer? Participants who are eligible and willing to undergo the TORe procedure to assist with weight loss will have the procedure completed either one of the two ways. All other care will be exactly the same between the two groups. Researchers will compare outcomes between the two procedure variations, looking at which one results in more weight loss, is more successful, and safer.

Sponsor: Stephen Firkins

You may qualify if…

  • ✓ Adult patients with history of Roux-en-Y gastric bypass and weight regain
  • ✓ Dilated gastrojejunal anastamosis as diagnosed on endoscopy
  • ✓ Patients undergoing standard of care for treatment of obesity with endoscopic revisional procedure (a.k.a. TORe) who are enrolled in the GI Bariatric Endoscopy program and clinic at the study site

You may not qualify if…

  • ✕ Prior revision of gastric bypass
  • ✕ Active and uncontrolled gastro-esophageal reflux disease defined as ≥ grade C esophagitis
  • ✕ Active untreated Helicobacter pylori infection
  • ✕ Malignancy newly diagnosed by endoscopy
  • ✕ Upper gastro-intestinal conditions such as ulcers, polyps, gastric varices, strictures, congenital or acquired intestinal telangiectasia or other abnormalities that preclude completion of TORe
  • ✕ Presence of gastrogastric or gastroenteric fistula
  • ✕ Inability to undergo general anesthesia
  • ✕ Participating in another ongoing clinical trial of an investigational weight loss drug or device

Where it's recruiting

Ohio

Cleveland

Source: ClinicalTrials.gov · NCT06131281 · last updated 2026-09-28

Comparing Reduction With ESD- Versus APC-TORe · TrialPath